The Clatterbridge Cancer Centre NHS Foundation Trust is one of the UK’s leading cancer centres
13/03/2026
Congratulations to our latest Star Award winner, Carol Barnes - Health Care Assistant on Ward 4, CCC-Liverpool.
Carol was nominated by a patient who said:
“When I came from the Intensive Therapy Unit, the first person I remember meeting was Carol - she was so bubbly and kind, and exactly what I needed at the time. It was when I realised that I couldn't walk and that I needed everything doing for me, I was so embarrassed, but Carol reassured me and put me at ease. It wasn't just the physical side, it was emotional - I thought I'd never walk again but she supported me to stay strong and build myself up. Carol always made me feel safe and supported, and when I was struggling mentally and emotionally after being in ITU, Carol went above and beyond to look after me and help me feel myself again."
Thank you, Carol, for the kindness, compassion and care you show to patients 💚
13/03/2026
Clatterbridge has become the top recruiting site in the UK for a major clinical research trial aiming to improve outcomes for people with an aggressive and fast-growing form of brain cancer.
CCC was already the first UK site to open the study into glioblastoma tumours and recruit the first patient in the UK to it.
Dave Winship from St Helens is the first patient to have his radiotherapy on our new Varian Halcyon linac with HyperSight technology at Clatterbridge Cancer Centre – Liverpool (CCC-Liverpool).
The new linac is the second Halcyon with HyperSight in our fleet of 10 radiotherapy treatment machines; the first began treating patients this time last year.
Unlike traditional linacs, which deliver treatment through a C-shaped arm that rotates around the patient, the Halcyon uses an O-shaped ring that is much quieter. And the shape makes it look like a scanner patients are already familiar with, reducing anxiety.
The HyperSight technology provides vastly enhanced imaging compared with traditional linacs. This means clinical teams can use the linac imaging to adjust treatment plans when needed, without patients having to have an additional CT planning scan.
Extended scans – which gather images over a longer length of a patient’s body and are vital when treating certain cancer types – can be completed quicker and more easily than on a traditional linac.
The new linac also offers surface-guided radiotherapy, funded by Clatterbridge Cancer Charity, reducing the need for the tiny tattoo dots that help clinical teams to ensure the treatment beam is precisely targeting cancer while minimising any risk to surrounding tissue.
Radiotherapy Treatment Expert Practitioner Rachael O’Sullivan said: “We are excited to have our second Halcyon linac with surface guided radiotherapy at Clatterbridge, enabling us to treat more patients within each working day due to the faster HyperSight technology.”
Martyn Gilmore, Lead Consultant Clinical Scientist for Radiotherapy, said: “We are always looking at how we can ensure patients benefit from the very latest advances in technology when they come to The Clatterbridge Cancer Centre. Having a second Halcyon linac with HyperSight further enhances our ability to deliver the very best care, and means even more patients can benefit.”
The Clatterbridge Cancer Centre is one of the UK’s leading and largest radiotherapy providers, delivering over 90,000 treatment fractions a year – more than almost any other hospital nationally.
12/03/2026
Congratulations to our first two Golden Ticket awardees, Ellie Jackson and Shannon Dixon 👏
The Golden Ticket is an inclusive recruitment pathway for exceptional final-year AHP and Nursing students, as well as T‑Level Health Cadets who complete placements at CCC. Students are nominated by their practice supervisors, educational tutors, practice facilitators or clinical teams, with the award recognising students who consistently demonstrate Trust values and excel in their placement performance.
Final year student nurse, Ellie, impressed the team during her management placement at CCC, showing kindness, advocating for patients and building strong rapport, especially with those needing extra reassurance. Congratulations Ellie, your leadership potential and compassionate practice are clear, and we couldn’t be prouder that you’ll be starting your professional career with us at CCC 💚
During her placement on Ward 4, Shannon made a strong impression through her calm presence, genuine warmth and the way she consistently connected with patients on a personal level. We’re delighted that Shannon plans to continue her nursing journey with CCC, bringing her compassion, positivity and strong professional values into the next stage of her career 💚
11/03/2026
Break free from smoking this No Smoking Day!
There is lots of free expert advice, support, and encouragement available so you're never alone on your quit journey.
Remember: a smoke-free life starts with a smoke-free day!
10/03/2026
📣 SAVE THE DATE: Working Together in Immuno-Oncology Toxicity Management: A Multidisciplinary Approach
Join Clatterbridge Cancer Centre’s Specialist Immuno-Oncology Toxicity Service on Friday 24th April 2026 at Holiday Inn Liverpool City Centre for an engaging, education-filled study day exploring the complexities of immunotherapy toxicity.
Through expert talks, case-based discussions, and multidisciplinary panels, this event will highlight the importance of cross-specialty collaboration in delivering safe, effective, and timely care for patients receiving immunotherapy.
Open to doctors of all grades, nurses, AHPs and pharmacists who provide care for patients undergoing immunotherapy. This event is also open to those that have attended our previous study days!
For further information, please visit the Clinical Education website 👉 https://orlo.uk/1lup7
08/03/2026
On International Women’s Day, we celebrate and thank the incredible women of CCC for the dedicated work they do to support patients, their families, and each other.
They make up 79% of our workforce, and their contribution is central to everything we do. From clinical care and research to leadership, operations and support services, women play a vital role across our organisation.
Happy International Women’s Day! 💜
06/03/2026
Ahead of on Sunday, we caught up with Dr Heulwen Sheldrick, Principal Speech and Language Therapist, to talk about the women who inspire her and her advice for those aspiring to a career in a similar field.
06/03/2026
If this week has convinced you it's time for a more fulfilling job, come and work for us! We've got some great opportunities available, including:
Cancer Support Worker, Senior Chemotherapy Staff Nurse, and Advanced Nurse Practitioner.
Congratulations to CCC's Dr Jess Hale for being our audit project winner at yesterday's Quality Improvement, Clinical Audit and Innovation Showcase Event at Hope Street Hotel.
Dr Hale's project 'Can-FIT!: A Multimodal prehabilitation and rehabilitation interactive website pilot' is built around how regular exercise can help people who have cancer to prepare for treatment that they may find challenging – and can help them better cope with the after effects of that treatment.
05/03/2026
Congratulations to our latest Star Award winner, Jess Scott- HCA, Wirral Hub Team
Jess was nominated by a patient who said:
“I would love to say a massive thank you on behalf of my best friend who we sadly lost last year. Jess left a footprint in her cancer journey. On this one particular day, she was fed up and tired and unloaded all of her feelings to Jess during her PICC line appointment. Jess listened and gave her the time she needed, she reassured her that the way she was feeling was normal and that she wasn't alone. After she had finished her dressing, she said to her, promise me one thing that you will go to Maggie’s and have a cup of coffee and a chat. Jess showed so much compassion and a listening ear during one of her darkest weeks and turned it into something positive. We enjoyed our visits to Maggie’s each week and met some amazing people, so thank you, Jess, you made such a difference in my friend’s last weeks of fighting. Jess empowered her to step out her comfort zone and socialise with others who understood what she was going through, so she didn't feel so alone. She always showed kindness and compassion. Jess was a guardian angel.”
Thank you, Jess, for showing so much kindness towards our patients 💚
05/03/2026
A CCC registrar has been appointed as one of two Lead Early Career Researchers for the UK Blood Cancer Research Network (UKBCRN) Lymphoma Research Group, working to develop the next generation of researchers.
Dr Lisa Jeffers, a first-year haematology registrar, will help shape the UKBCRN’s Early Career Researcher network in the two-year national role.
She will help to ensure researchers from a broad range of backgrounds can access opportunities and contribute to the future of UK blood cancer research.
Be the first to know and let us send you an email when The Clatterbridge Cancer Centre posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
The Clatterbridge Cancer Centre NHS Foundation Trust is one of the UK’s leading cancer centres providing highly specialist cancer care to a population of 2.3m people across Cheshire, Merseyside and the surrounding areas including the Isle of Man.
We are based in Wirral, Merseyside supported by a £17m radiotherapy treatment centre in Aintree, Liverpool. We also operate specialist chemotherapy clinics in seven of Merseyside’s district hospitals and deliver a pioneering Treatment at Home service.
Together, this enables us to provide a comprehensive range of inpatient care, advanced radiotherapy, chemotherapy and other systemic anti-cancer therapies (i.e. medicines) including gene therapies and immunotherapies. We are also the only facility in the UK providing low-energy proton beam therapy to treat rare eye cancers and host the region’s Teenage and Young Adult Unit, (supported by the Teenage Cancer Trust).
We are a tertiary cancer centre which means we see patients who have already been diagnosed and referred to us by other hospitals. We provide non-surgical cancer care e.g. chemotherapy and radiotherapy for solid tumours and blood cancers.
Our services include:
Academic oncology – professors and senior clinical lecturers appointed jointly with the University of Liverpool
Acute oncology – specialist cancer support in A&E and acute care in other hospitals
Chemotherapy and other systemic anti-cancer treatments (SACT). These are drug treatments for cancer and include gene therapies, immunotherapies and other molecular agents
Haemato-oncology – in July 2017 the management of the Royal Liverpool University Hospital’s Haemato-oncology service transferred to The Clatterbridge Cancer Centre. This service provides inpatient and outpatient care for acute leukaemia; chronic leukaemia; lymphoma; myeloma and bone marrow (stem cell) transplant
Eye proton therapy – we have the UK’s only low-energy proton beam therapy facility for treating rare eye tumours
Imaging and pre-treatment radiotherapy (diagnostic imaging / treatment planning) – we have PET-CT, CT, MRI, x-ray facilities and treatment planning
Inpatient wards – we have 73 inpatient beds across our three wards on our Wirral site
Pharmacy – we manufacture all the chemotherapy doses for solid tumour cancers in Cheshire & Merseyside
Physics – our physicists provide essential scientific support for radiotherapy treatment
Radiotherapy – we have 10 linear accelerators (radiotherapy treatment machines). Six at the Wirral site; three at the Aintree site; one in the Clatterbridge Private Clinic
Research & development – we carry out leading-edge clinical trials of new cancer treatments. Our BioBank of donated tissue provides a valuable resource for cancer researchers
Supportive care – including physiotherapy, psychological support, palliative care, speech and language therapy, occupational therapy, dietetics, cancer information, financial / benefits advice, and survivorship / living with and beyond cancer
Triage & assessment – we provide rapid-access assessment clinics and 24-hour phone support for patients who need urgent advice or care while having cancer treatment
We are expanding and improving cancer care even further with the development of a new 11-floor specialist cancer hospital in the heart of Liverpool. The new cancer hospital is due to open in 2020 and will provide highly-specialist cancer care for people with blood cancers and solid tumours. Although the Liverpool hospital will become our main base, we will also continue providing services at our current site in Wirral and our satellite radiotherapy centre on the Aintree site.
Being located in central Liverpool alongside the University of Liverpool and Royal Liverpool University Hospital will significantly improve care for people with cancer:
Our main base will be closer to the majority of the population we serve, which stretches from Southport down to Wirral and across to Widnes / Warrington. People who live closer to Wirral / Aintree will still be able to access care locally as we’re keeping our current sites
Unlike now, we will be co-located with a major acute teaching hospital providing rapid access to intensive care and other key medical and surgical specialties when patients need them. At the moment these patients have to be transferred by emergency ambulance to other hospitals
We will be at the heart of a thriving research and healthcare campus with the University of Liverpool, NHS and other key research partners, enabling even more ground breaking cancer research and clinical trials.
You can find out more about the new building here.
